Persistent pulmonary hypertension of the newborn (PPHN) treated with inhaled nitric oxide: preliminary hearing outcomes.
The hearing of 28 children, born with a diagnosis of persistent pulmonary hypertension of the newborn (PPHN) and treated with inhaled nitric oxide, was followed. The latest test for the children varied from 5 to 30 months. Of this group, three children had mild conductive hearing losses; no child had a significant sensorineural hearing loss.
Fujikawa
S
S
Department of Neurology, University of California, Irvine, Orange 92668, USA.
Yang
L
L
Waffarn
F
F
Lerner
M
M
D001299:Audiometry / Q000379:methods; D016057:Evoked Potentials, Auditory, Brain Stem; D015199:Extracorporeal Membrane Oxygenation / Q000379:methods; D005500:Follow-Up Studies; D006314:Hearing Loss, Conductive / Q000175:diagnosis*; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D018377:Neurotransmitter Agents / Q000008:administration & dosage*; D009569:Nitric Oxide / Q000008:administration & dosage*; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy*; D010775:Photic Stimulation; D015995:Prevalence; D011446:Prospective Studies
D018377:Neurotransmitter Agents; D009569:Nitric Oxide